Mandibular third molar surgery is a common procedure that often results in postoperative pain, swelling, and trismus. These sequelae present significant challenges for both patients and clinicians. To address these issues, various management approaches have been explored. A recent study compared the efficacy of transbuccal mucoadhesive patches containing diclofenac sodium versus oral tablets in controlling these postoperative complications.
A prospective split-mouth, single-blinded study was conducted at AMC Dental College and Hospital in Ahmedabad. The study aimed to assess the efficacy of two different routes of administering diclofenac sodium for managing postoperative pain, swelling, and trismus following the surgical removal of mandibular third molars.
The study included patients aged 18 to 45 years who required surgical removal of bilaterally symmetrical mandibular third molars under local anesthesia. Patients who had consumed analgesics within 24 hours prior to the procedure were excluded from the study. A total of 146 patients were initially screened, but only 37 subjects met all inclusion criteria.
Participants were divided into two groups:
- Study Group: Received transbuccal mucoadhesive patches containing 20 mg diclofenac sodium.
- Control Group: Received oral tablets containing 50 mg diclofenac sodium.
The primary outcome variable was postoperative pain measured using a visual analog scale (VAS). Secondary outcome variables included swelling, mouth opening, onset of analgesic effect, and adverse events. Two categories of covariates were considered:
- Demographic: Age and gender.
- Perioperative: Pattern of impaction.